EP2838517
ORALLY AVAILABLE PHARMACEUTICAL FORMULATION SUITABLE FOR IMPROVED MANAGEMENT OF MOVEMENT DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.4.2013EP published:
18.10.2017EP application number:
13725557.6
EPO information:
European Patent Register
Max expiry date:
17.4.2033
Title:
ORALLY AVAILABLE PHARMACEUTICAL FORMULATION SUITABLE FOR IMPROVED MANAGEMENT OF MOVEMENT DISORDERS
Timeline
Today
18.4.2013EP application
18.10.2017EP Publication
Owner
Name:
Contera Pharma APSAddress:
Ole Maaløes Vej 3, 2200, Copenhagen N, DK
Inventor
Name:
HANSEN, John BondoAddress:
Copenhagen Ø, DK
Name:
THOMSEN, Mikael S.Address:
Hvidovre, DK
Name:
MIKKELSEN, Jens D.Address:
Lyngby, DK
Name:
NIELSEN, Peter GudmundAddress:
Værløse, DK
Name:
KREILGAARD, MadsAddress:
Farum, DK
Priority
Number:
201270196Date:
18.4.2012Country:
DK
Number:
PCT/DK2012/050190Date:
1.6.2012Country:
WO
Number:
201270755Date:
4.12.2012Country:
DK
Classification
Categories:
A61K 9/22, A61K 9/52, A61K 45/06, A61K 31/422, A61K 31/454, A61K 31/4545, A61K 31/496, A61K 31/505, A61P 25/14, A61P 25/16, A61K 9/28